| Name: | New American Therapeutics, Inc |
| Jurisdiction: | MISSISSIPPI |
| Business Type: | Profit Corporation |
| Status: | Good Standing |
| Effective Date: | 08 Oct 2021 (4 years ago) |
| Business ID: | 1306935 |
| State of Incorporation: | DELAWARE |
| Principal Office Address: | 300 INTERPACE PARKWAY, MORRIS CORPORATE CENTER 1, BUILDING C3PARSIPPANY, NJ 07054 |
| Name | Role | Address |
|---|---|---|
| C. T. CORPORATION SYSTEM | Agent | 645 LAKELAND EAST DRIVE STE 101, FLOWOOD, MS 39232 |
| Name | Role | Address |
|---|---|---|
| Michael Anderson | Director | 300 Interpace Parkway, Morris Corporate Center 1, Building C3, Parsippany, NJ 07054 |
| Michael Farrell | Director | 300 Interpace Parkway, Morris Corporate Center 1, Building C3, Parsippany, NJ 07054 |
| Sumner Anderson | Director | 300 Interpace Parkway, Morris Corporate Center 1, Building C3, Parsippany, NJ 07054 |
| Name | Role | Address |
|---|---|---|
| Michael Farrell | Treasurer | 300 Interpace Parkway, Morris Corporate Center 1, Building C3, Parsippany, NJ 07054 |
| Name | Role | Address |
|---|---|---|
| Phillandas Thompson | Secretary | 300 Interpace Parkway, Morris Corporate Center 1, Building C3, Parsippany, NJ 07054 |
| Name | Role | Address |
|---|---|---|
| Michael Anderson | Chief Executive Officer | 300 Interpace Parkway, Morris Corporate Center 1, Building C3, Parsippany, NJ 07054 |
| Type | Status | Filed Date | Description |
|---|---|---|---|
| Annual Report | Filed | 2025-02-14 | Annual Report For New American Therapeutics, Inc |
| Annual Report | Filed | 2024-01-19 | Annual Report For New American Therapeutics, Inc |
| Annual Report | Filed | 2023-05-06 | Annual Report For New American Therapeutics, Inc |
| Annual Report | Filed | 2022-04-21 | Annual Report For New American Therapeutics, Inc |
| Formation Form | Filed | 2021-10-08 | Formation For New American Therapeutics, Inc |
Date of last update: 08 Apr 2025
Sources: Mississippi Secretary of State
